Back
Ocular Therapeutix Quote, Financials, Valuation and Earnings
Sponsored
OCUL
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
76
OCUL
Ocular Therapeutix
Last Price:
10.61
Seasonality Move:
21.32%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Ocular Therapeutix Price Quote
$10.61
-0.35 (-3.19%)
(Updated: November 12, 2024 at 5:55 PM ET)
Ocular Therapeutix Key Stats
Buy
76
Ocular Therapeutix (OCUL)
is a Buy
Day range:
$10.76 - $11.25
52-week range:
$2.02 - $11.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.22
P/B ratio:
4.52%
Volume:
514.1K
Avg. volume:
1.2M
1-year change:
420.67%
Market cap:
$1.7B
Revenue:
$58.4M
EPS:
$-1.35
How Much Does Ocular Therapeutix Make?
-
How Much Are Ocular Therapeutix's Sales Annually?
OCUL Revenues are $58.4M -
How Much Profit Does Ocular Therapeutix's Make A Year?
OCUL net income is -$80.7M
Is Ocular Therapeutix Growing As A Company?
-
What Is Ocular Therapeutix's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ocular Therapeutix Stock Price Performance
-
Did Ocular Therapeutix Stock Go Up Last Month?
Ocular Therapeutix share price went up by 12.07% last month -
Did OCUL's Share Price Rise Over The Last Year?
OCUL share price rose by 420.67% over the past 1 year
What Is Ocular Therapeutix 52-Week High & Low?
-
What Is Ocular Therapeutix’s 52-Week High Share Price?
Ocular Therapeutix has traded as high as $11.78 over the past 52 weeks -
What Is Ocular Therapeutix’s 52-Week Low Share Price?
Ocular Therapeutix has traded as low as $2.02 over the past 52 weeks
Ocular Therapeutix Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ocular Therapeutix?
-
How Much Debt Does Ocular Therapeutix Have?
Total long term debt quarterly is $67.1M -
How Much Cash Does Ocular Therapeutix Have?
Cash and short term investments quarterly total is $459.7M -
What Is Ocular Therapeutix’s Book Value Per Share?
Book value per share is 2.43
Is Ocular Therapeutix Cash Flow Positive?
-
What Is OCUL Cash Flow From Operations?
Cash flow from operations (TTM) is -$88.9M -
What Is Ocular Therapeutix’s Cash Flow From Financing?
Cash flow from financing (TTM) is $483.5M -
What Is Ocular Therapeutix’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.7M
Ocular Therapeutix Return On Invested Capital
-
Is Management Doing A Good Job?
OCUL return on invested capital is -56.45% -
What Is Ocular Therapeutix Return On Assets?
ROA measures how assets are converting to revenues and is -43.43% -
What Is OCUL Return On Equity?
ROE is a measure of profitability and is -77.93%
Ocular Therapeutix Earnings Date & Stock Price
-
What Is Ocular Therapeutix's Stock Price Today?
A single share of OCUL can be purchased today for 10.96 -
What Is Ocular Therapeutix’s Stock Symbol?
Ocular Therapeutix trades on the nasdaq under the ticker symbol: OCUL -
When Is Ocular Therapeutix’s Next Earnings Date?
The next quarterly earnings date for Ocular Therapeutix is scheduled on November 14, 2024 -
When Is OCUL's next ex-dividend date?
Ocular Therapeutix's next ex-dividend date is November 13, 2024 -
How To Buy Ocular Therapeutix Stock?
You can buy Ocular Therapeutix shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ocular Therapeutix Competitors
-
Who Are Ocular Therapeutix's Competitors?
Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
Ocular Therapeutix Dividend Yield
-
What Is OCUL Dividend Yield?
Ocular Therapeutix’s dividend yield currently is 0% -
What Is Ocular Therapeutix’s Payout Ratio?
Ocular Therapeutix’s payout ratio is 0% -
When Did Ocular Therapeutix Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Ocular Therapeutix’s Dividend Per Share?
Ocular Therapeutix pays a dividend of $0.00 per share
Ocular Therapeutix Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -21.88% |
Revenue: | 8.26% | 3.75% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 16.56 |
Upside from Last Price: | 51.05% |